LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 16

Search options

  1. Article: HIV in adolescents and young adults: half of all new infections in the United States.

    Futterman, Donna C

    Topics in HIV medicine : a publication of the International AIDS Society, USA

    2005  Volume 13, Issue 3, Page(s) 101–105

    Abstract: ... counseling and testing to young people. This article summarizes a presentation by Donna Futterman, MD ...

    Abstract Half of new HIV infections in the United States are in individuals aged 13 to 24 years, accounting for 20,000 new infections annually, or 1 every hour. Two thirds of infected youth contract HIV sexually, and more than 60% of new infections are in young women. Approximately 75% of infected youth are in racial or ethnic minority groups. More than one third of HIV-infected young people have not been tested for HIV infection, and the majority of homosexual HIV-infected youth are unaware of their infection status. Increased efforts are needed in comprehensive sex education, including safer sex practices, bringing young people into health care networks, increasing health care provider awareness of risk, and extending counseling and testing to young people. This article summarizes a presentation by Donna Futterman, MD, at the 7th Annual Clinical Conference for Ryan White CARE Act Title I, II, III, and IV Grantees, held in August 2004 in Washington, DC.
    MeSH term(s) Adolescent ; Adolescent Behavior ; Adult ; Ethnic Groups ; Female ; HIV Infections/epidemiology ; HIV Infections/ethnology ; HIV Infections/transmission ; Humans ; Male ; Minority Groups ; Risk Factors ; Risk-Taking ; Sex Education ; Sexual Behavior ; United States/epidemiology
    Language English
    Publishing date 2005-08
    Publishing country United States
    Document type Journal Article
    ISSN 1542-8826
    ISSN 1542-8826
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: HIV and AIDS in adolescents.

    Futterman, Donna C

    Adolescent medicine clinics

    2004  Volume 15, Issue 2, Page(s) 369–391

    Abstract: HIV infection in adolescents continues to challenge health providers, policymakers, and advocates for youth. There will be no relief from its complexities soon. Primary care providers are in a unique position to use effective HIV prevention and care ... ...

    Abstract HIV infection in adolescents continues to challenge health providers, policymakers, and advocates for youth. There will be no relief from its complexities soon. Primary care providers are in a unique position to use effective HIV prevention and care interventions. Successful programs move beyond moralism to realism. They show a willingness to engage young people and their families in a sensitive dialogue about the needs of youthful sexual development. Youth at high risk for HIV should be identified and referred to comprehensive care and counseling as soon as possible. HIV-positive youth need intensive individual and group interventions to remain healthy and reduce transmission to others. To protect their patient population, health care providers will need to commit time and effort to making adolescents services visible, flexible, affordable, confidential, culturally appropriate, and universally available.
    MeSH term(s) AIDS Serodiagnosis ; AIDS Vaccines ; Adaptation, Psychological ; Adolescent ; Anti-HIV Agents/therapeutic use ; Counseling ; Female ; HIV Infections/diagnosis ; HIV Infections/epidemiology ; HIV Infections/psychology ; HIV Infections/therapy ; Humans ; Male ; Patient Compliance ; Risk Factors ; United States/epidemiology
    Chemical Substances AIDS Vaccines ; Anti-HIV Agents
    Language English
    Publishing date 2004-09-25
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2146389-X
    ISSN 1547-3368
    ISSN 1547-3368
    DOI 10.1016/j.admecli.2004.02.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Expanded HIV Testing Strategy Leveraging the Electronic Medical Record Uncovers Undiagnosed Infection Among Hospitalized Patients.

    Felsen, Uriel R / Cunningham, Chinazo O / Heo, Moonseong / Futterman, Donna C / Weiss, Jeffrey M / Zingman, Barry S

    Journal of acquired immune deficiency syndromes (1999)

    2017  Volume 75, Issue 1, Page(s) 27–34

    Abstract: Background: Routine HIV testing of hospitalized patients is recommended, but few strategies to expand testing in the hospital setting have been described. We assessed the impact of an electronic medical record (EMR) prompt on HIV testing for ... ...

    Abstract Background: Routine HIV testing of hospitalized patients is recommended, but few strategies to expand testing in the hospital setting have been described. We assessed the impact of an electronic medical record (EMR) prompt on HIV testing for hospitalized patients.
    Methods: We performed a pre-post study at 3 hospitals in the Bronx, NY. We compared the proportion of admissions of patients 21-64 years old with an HIV test performed, characteristics of patients tested, and rate of new HIV diagnoses made by screening while an EMR prompt recommending HIV testing was inactive vs. active. The prompt appeared for patients with no previous HIV test or a high-risk diagnosis after their last HIV test.
    Results: Among 36,610 admissions while the prompt was inactive, 9.5% had an HIV test performed. Among 18,943 admissions while the prompt was active, 21.8% had an HIV test performed. Admission while the prompt was active was associated with increased HIV testing among total admissions [adjusted odds ratio (aOR) 2.78, 95% confidence interval (CI): 2.62 to 2.96], those without a previous HIV test (aOR 4.03, 95% CI: 3.70 to 4.40), and those with a previous negative test (aOR 1.52, 95% CI: 1.37 to 1.68) (P < 0.0001 for all). Although the prompt was active, testing increased across all patient characteristics. New HIV diagnoses made by screening increased from 8.2/100,000 admissions to 37.0/100,000 admissions while the prompt was inactive and active, respectively (OR 4.51 95% CI: 1.17 to 17.45, P = 0.03).
    Conclusions: An EMR prompt for hospitalized patients was associated with a large increase in HIV testing, a diversification of patients tested, and an increase in diagnoses made by screening.
    MeSH term(s) Adult ; Diagnostic Tests, Routine/statistics & numerical data ; Electronic Health Records ; Female ; HIV Infections/diagnosis ; HIV Infections/epidemiology ; Hospitalization ; Humans ; Male ; Mass Screening/statistics & numerical data ; Middle Aged ; New York City/epidemiology ; Non-Randomized Controlled Trials as Topic ; Prospective Studies ; Young Adult
    Language English
    Publishing date 2017-01-31
    Publishing country United States
    Document type Journal Article
    ZDB-ID 645053-2
    ISSN 1944-7884 ; 1077-9450 ; 0897-5965 ; 0894-9255 ; 1525-4135
    ISSN (online) 1944-7884 ; 1077-9450
    ISSN 0897-5965 ; 0894-9255 ; 1525-4135
    DOI 10.1097/QAI.0000000000001299
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: HIV in Adolescents.

    Catallozzi, Marina / Futterman, Donna C

    Current infectious disease reports

    2005  Volume 7, Issue 5, Page(s) 401–405

    Abstract: Adolescence is a time of dramatic physical, emotional, cognitive, and social change that brings new vulnerabilities. Youth represent half of all new HIV infections in the United States and the rest of the world. The number of newly infected adolescents ... ...

    Abstract Adolescence is a time of dramatic physical, emotional, cognitive, and social change that brings new vulnerabilities. Youth represent half of all new HIV infections in the United States and the rest of the world. The number of newly infected adolescents who acquire the disease behaviorally and the number of perinatally infected children surviving into adolescence have both contributed to this growth. This article reviews the most recent epidemiology of HIV/AIDS in adolescents, gives guidance on clinical practice, including medical and psychosocial care, and examines prevention issues, including counseling and testing, which are needed to make programs effective for youth.
    Language English
    Publishing date 2005-08-10
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2019948-X
    ISSN 1534-3146 ; 1523-3847
    ISSN (online) 1534-3146
    ISSN 1523-3847
    DOI 10.1007/s11908-005-0015-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: An expanded HIV screening strategy in the Emergency Department fails to identify most patients with undiagnosed infection: insights from a blinded serosurvey.

    Felsen, Uriel R / Torian, Lucia V / Futterman, Donna C / Stafford, Stephen / Xia, Qiang / Allan, David / Esses, David / Cunningham, Chinazo O / Weiss, Jeffrey M / Zingman, Barry S

    AIDS care

    2019  Volume 32, Issue 2, Page(s) 202–208

    Abstract: Screening for HIV in Emergency Departments (EDs) is recommended to address the problem of undiagnosed HIV. Serosurveys are an important method for estimating the prevalence of undiagnosed HIV and can provide insight into the effectiveness of an HIV ... ...

    Abstract Screening for HIV in Emergency Departments (EDs) is recommended to address the problem of undiagnosed HIV. Serosurveys are an important method for estimating the prevalence of undiagnosed HIV and can provide insight into the effectiveness of an HIV screening strategy. We performed a blinded serosurvey in an ED offering non-targeted HIV screening to determine the proportion of patients with undiagnosed HIV who were diagnosed during their visit. The study was conducted in a high-volume, urban ED and included patients who had blood drawn for clinical purposes and had sufficient remnant specimen to undergo deidentified HIV testing. Among 4752 patients not previously diagnosed with HIV, 1403 (29.5%) were offered HIV screening and 543 (38.7% of those offered) consented. Overall, undiagnosed HIV was present in 12 patients (0.25%): six among those offered screening (0.4%), and six among those not offered screening (0.2%). Among those with undiagnosed HIV, two (16.7%) consented to screening and were diagnosed during their visit. Despite efforts to increase HIV screening, more than 80% of patients with undiagnosed HIV were not tested during their ED visit. Although half of those with undiagnosed HIV were missed because they were not offered screening, the yield was further diminished because a substantial proportion of patients declined screening. To avoid missed opportunities for diagnosis in the ED, strategies to further improve implementation of HIV screening and optimize rates of consent are needed.
    MeSH term(s) AIDS Serodiagnosis/methods ; Adolescent ; Adult ; Aged ; Emergency Service, Hospital/statistics & numerical data ; Female ; HIV Infections/diagnosis ; HIV Infections/epidemiology ; Hospitals, Urban ; Humans ; Male ; Mass Screening/methods ; Mass Screening/organization & administration ; Middle Aged ; Prevalence ; Seroepidemiologic Studies ; Serologic Tests ; Young Adult
    Language English
    Publishing date 2019-05-30
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1012651-x
    ISSN 1360-0451 ; 0954-0121
    ISSN (online) 1360-0451
    ISSN 0954-0121
    DOI 10.1080/09540121.2019.1619663
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Adolescents and HIV: prevention and clinical care.

    Spiegel, Hans M L / Futterman, Donna C

    Current HIV/AIDS reports

    2009  Volume 6, Issue 2, Page(s) 100–107

    Abstract: The incidence of HIV infection has increased to alarming proportions among minority youth, in particular among young men who have sex with men and among teenage girls. The unique socioeconomic, behavioral, and emotional vulnerability of adolescents for ... ...

    Abstract The incidence of HIV infection has increased to alarming proportions among minority youth, in particular among young men who have sex with men and among teenage girls. The unique socioeconomic, behavioral, and emotional vulnerability of adolescents for sexually transmitted diseases, including HIV, requires early identification of HIV infection for linkage to care. Differences in the clinical and psychosocial presentations of youth with perinatally versus behavioral acquired HIV infection are important and influence the acceptance of illness, self-efficacy, and antiretroviral treatment adherence. The ideal multidisciplinary team approach of culturally sensitive services for youth integrates clinical care, psychosocial and peer support interventions, transition planning, primary and secondary prevention, as well as comprehensive reproductive adolescent health services.
    MeSH term(s) Adolescent ; Adolescent Behavior ; Female ; HIV Infections/drug therapy ; HIV Infections/epidemiology ; HIV Infections/prevention & control ; HIV Infections/virology ; HIV-1 ; Humans ; Male ; Prevalence ; Psychology ; Sexual Behavior ; Sexually Transmitted Diseases/drug therapy ; Sexually Transmitted Diseases/epidemiology ; Sexually Transmitted Diseases/prevention & control ; United States/epidemiology
    Language English
    Publishing date 2009-04-09
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2151206-1
    ISSN 1548-3576 ; 1548-3568
    ISSN (online) 1548-3576
    ISSN 1548-3568
    DOI 10.1007/s11904-009-0015-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Increased Antiretroviral Therapy Use and Virologic Suppression in the Bronx in the Context of Multiple HIV Prevention Strategies.

    Hanna, David B / Felsen, Uriel R / Ginsberg, Mindy S / Zingman, Barry S / Beil, Robert S / Futterman, Donna C / Strickler, Howard D / Anastos, Kathryn

    AIDS research and human retroviruses

    2016  Volume 32, Issue 10-11, Page(s) 955–963

    Abstract: Multiple population-based HIV prevention strategies from national, state, local, and institutional levels have been implemented in the Bronx, which has one of the highest HIV prevalences in the U.S. We examined changes in antiretroviral therapy (ART) use ...

    Abstract Multiple population-based HIV prevention strategies from national, state, local, and institutional levels have been implemented in the Bronx, which has one of the highest HIV prevalences in the U.S. We examined changes in antiretroviral therapy (ART) use and associated outcomes between 2007 and 2014 among patients seen at one of >20 outpatient clinics affiliated with the largest Bronx HIV care provider. Among eligible HIV-infected patients age ≥13 years, we examined annual trends in ART use, mean HIV RNA level, and virologic suppression (<200 copies/ml) overall and among prespecified subgroups. In a subset with suppressed HIV RNA at the end of each year, we determined the percentage whose levels remained suppressed within the next year. Regression models assessed disparities in outcomes. Among 7,196 patients (median age 50, 47% Hispanic, 45% black), we identified consistent increases over time in the percent prescribed ART (78% in 2007 to 93% in 2014) and with virologic suppression (58% to 80%), as mean HIV RNA decreased (351 to 73 copies/ml) (all p < .001). Sustained virologic suppression improved markedly beginning in 2011, coinciding with local test-and-treat initiatives and adoption of expanded treatment guidelines. While disparities among population groups were most pronounced for sustained virologic suppression, those aged 13-24 fared relatively poorly for all outcomes examined (e.g., rate ratio 0.57 for virologic suppression, 95% confidence interval 0.52-0.62, vs. age 65+). Population-wide HIV prevention strategies coincided with improvements in virologic suppression among most population groups. However, more attention is needed to address continued disparities in the HIV care continuum among young people.
    Language English
    Publishing date 2016-10
    Publishing country United States
    Document type Journal Article
    ZDB-ID 639130-8
    ISSN 1931-8405 ; 0889-2229
    ISSN (online) 1931-8405
    ISSN 0889-2229
    DOI 10.1089/AID.2015.0345
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: HIV self-testing and STI self-collection via mobile apps: experiences from two pilot randomized controlled trials of young men who have sex with men.

    Biello, Katie B / Horvitz, Casey / Mullin, Shelby / Mayer, Kenneth H / Scott, Hyman / Coleman, Kenneth / Dormitzer, Julian / Norelli, Jenna / Hightow-Weidman, Lisa / Sullivan, Patrick / Mimiaga, Matthew J / Buchbinder, Susan / Bojan, Kelly / Futterman, Donna / Emmanuel, Patricia / Liu, Albert

    mHealth

    2021  Volume 7, Page(s) 26

    Abstract: Background: Young men who have sex with men (YMSM) are disproportionately impacted by HIV and other sexually transmitted infections (STIs) in the United States (US) and have low rates of HIV/STI testing. Provision of HIV self-testing and STI self- ... ...

    Abstract Background: Young men who have sex with men (YMSM) are disproportionately impacted by HIV and other sexually transmitted infections (STIs) in the United States (US) and have low rates of HIV/STI testing. Provision of HIV self-testing and STI self-collection can increase testing rates, and access to these kits through mobile applications (apps) could help facilitate YMSM using HIV self-testing and STI self-collection.
    Methods: Data for this study comes from two pilot randomized controlled trials (RCTs) of mobile apps within the Adolescent Trials Network-LYNX and MyChoices-aimed to increase HIV/STI testing among YMSM (age 15-24) who had not recently tested for HIV and were at high risk for HIV acquisition across five US cities. Both apps include the ability to order a HIV self-test with rapid results and a kit for STI self-collection and mailing of samples for syphilis, gonorrhea and chlamydia to a lab for testing. Using assessments of app users (n=80) at pre-randomization and at 3- and 6-months post-randomization and online interview data from a purposive sample of app users (n=37), we report on experiences and lessons learned with HIV self-testing and STI self-collection kits ordered via the apps.
    Results: Participants were on average 20.7 years of age (SD =2.4), and 49% were non-White or multiple race/ethnicity. Sixty-three percent had a prior HIV test. Over half (58%) had a prior STI test, but only 3% had tested within the past 3 months. Nearly two-thirds ordered an HIV self-testing kit; of whom, 75% reported using at least one self-test kit over the study period. STI self-collection kit ordering rates were also high (54%); however, STI self-collection kit return rates were lower (13%), but with a high positivity rate (5.3%). Both HIV self-testing and STI self-collection kits were highly acceptable, and 87% reported that it was extremely/very helpful to be able to order these kits through the apps. The most common reason for not ordering the HIV/STI kits was preferring to test at a clinic. In interviews, participants expressed feeling empowered by being able to test at home; however, they also raised concerns around STI sample collection.
    Conclusions: HIV self-testing and STI self-collection kit ordering via mobile apps is feasible, acceptable and may show promise in increasing testing rates among YMSM. The LYNX and MyChoices apps are currently being tested in a full-scale efficacy trial, and if successful, these innovative mobile apps could be scaled up to efficiently increase HIV/STI testing among youth across the US.
    Language English
    Publishing date 2021-04-20
    Publishing country China
    Document type Journal Article
    ISSN 2306-9740
    ISSN 2306-9740
    DOI 10.21037/mhealth-20-70
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Qualitative Study on the Acceptability of and Adherence to a Vaginal Ring for HIV Prophylaxis Among Adolescent Girls.

    Baker, Zoë / Javanbakht, Marjan / Moore, Janell / Brosnan, Hannah / Squires, Kathleen / Bunge, Katherine / Zimet, Gregory / Mensch, Barbara / Soto-Torres, Lydia / Kapogiannis, Bill / Levy, Lisa / Hoesley, Craig / Reirden, Daniel / Gaur, Aditya / Mayer, Kenneth / Futterman, Donna / Gorbach, Pamina

    Journal of acquired immune deficiency syndromes (1999)

    2021  Volume 87, Issue 3, Page(s) 944–950

    Abstract: Objective: This study aims to assess the product-related, relationship-related, and sex-related factors that act as facilitators and barriers to the acceptability of a vaginal ring (VR) for HIV prevention among adolescent girls.: Design: Qualitative ... ...

    Abstract Objective: This study aims to assess the product-related, relationship-related, and sex-related factors that act as facilitators and barriers to the acceptability of a vaginal ring (VR) for HIV prevention among adolescent girls.
    Design: Qualitative study.
    Methods: Ninety-six girls aged 15-17 years from 6 urban US sites were enrolled in MTN-023/IPM 030, a 24-week randomized controlled trial, for assessing the safety and acceptability of a dapivirine VR for HIV prevention. At week 24, 21 girls were randomly selected to participate in in-depth interviews. Interviews were transcribed verbatim and data analyzed using a thematic analysis approach. Facilitators and barriers to VR acceptability related to participants' relationships, sexual activity, and characteristics of the VR product were identified.
    Results: Factors related to relationships rarely seemed to act as barriers to VR acceptability; most participants disclosed VR use to sexual partners, and positive reactions from sexual partners, which were common, seemed to facilitate VR acceptability. Emotional and/or physical discomfort surrounding VR use during sex was mentioned occasionally as a barrier to VR acceptability. Product characteristics were most frequently mentioned as barriers to VR acceptability. Many participants reported concerns about the large size of the VR on first impression. Although most found the VR comfortable, some reported pain with VR insertion. Several participants were concerned about VR cleanliness, particularly during menstruation.
    Conclusion: Product considerations, specifically size and use during menstruation, were the most commonly reported barriers to VR acceptability in this study. Adolescent girls may require additional counseling to assuage product concerns regarding a VR for HIV prevention.
    MeSH term(s) Administration, Intravaginal ; Adolescent ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/adverse effects ; Anti-HIV Agents/therapeutic use ; Contraceptive Devices, Female ; Female ; HIV Infections/prevention & control ; HIV-1 ; Humans ; Medication Adherence ; Pre-Exposure Prophylaxis/methods
    Chemical Substances Anti-HIV Agents
    Language English
    Publishing date 2021-03-03
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, N.I.H., Extramural
    ZDB-ID 645053-2
    ISSN 1944-7884 ; 1077-9450 ; 0897-5965 ; 0894-9255 ; 1525-4135
    ISSN (online) 1944-7884 ; 1077-9450
    ISSN 0897-5965 ; 0894-9255 ; 1525-4135
    DOI 10.1097/QAI.0000000000002674
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Pre-vaccination prevalence of anogenital and oral human papillomavirus in young HIV-infected men who have sex with men.

    Kahn, Jessica A / Belzer, Marvin / Chi, Xiaofei / Lee, Jeannette / Gaur, Aditya H / Mayer, Kenneth / Martinez, Jaime / Futterman, Donna C / Stier, Elizabeth A / Paul, Mary E / Chiao, Elizabeth Y / Reirden, Daniel / Goldstone, Steven E / Ortiz Martinez, Ana P / Cachay, Edward R / Barroso, Luis F / Da Costa, Maria / Wilson, Craig M / Palefsky, Joel M

    Papillomavirus research (Amsterdam, Netherlands)

    2019  Volume 7, Page(s) 52–61

    Abstract: The aims of this study were to: 1) determine prevalence of anogenital and oral HPV, 2) determine concordance between HPV at anal, perianal, scrotal/penile, and oral sites; and 3) describe factors associated with anogenital HPV types targeted by the 9- ... ...

    Abstract The aims of this study were to: 1) determine prevalence of anogenital and oral HPV, 2) determine concordance between HPV at anal, perianal, scrotal/penile, and oral sites; and 3) describe factors associated with anogenital HPV types targeted by the 9-valent vaccine. Data were collected from 2012 to 2015 among men who have sex with men 18-26 years of age enrolled in a vaccine trial (N = 145). Penile/scrotal, perianal, anal, and oral samples were tested for 61 HPV types. Logistic regression was used to identify factors associated with types in the 9-valent vaccine. Participants' mean age was 23.0 years, 55.2% were African-American, and 26.2% were Hispanic; 93% had anal, 40% penile, and 6% oral HPV. Among those with anogenital infection, 18% had HPV16. Concordance was low between anogenital and oral sites. Factors independently associated with a 9-valent vaccine-type HPV were: race (African-American vs. White, OR=2.67, 95% CI=1.11-6.42), current smoking (yes vs. no, OR=2.37, 95% CI=1.03-5.48), and number of recent receptive anal sex partners (2+ vs. 0, OR=3.47, 95% CI=1.16-10.4). Most MSM were not infected with HPV16 or HPV18, suggesting that they may still benefit from HPV vaccination, but anogenital HPV was very common, highlighting the importance of vaccinating men before sexual initiation. CLINICAL TRIAL NUMBER: NCT01209325.
    MeSH term(s) Adolescent ; Adult ; Anal Canal/virology ; Genitalia, Male/virology ; HIV Infections/complications ; Homosexuality, Male ; Humans ; Male ; Mouth/virology ; Papillomaviridae/classification ; Papillomaviridae/isolation & purification ; Papillomavirus Infections/epidemiology ; Prevalence ; Young Adult
    Language English
    Publishing date 2019-01-15
    Publishing country Netherlands
    Document type Clinical Trial, Phase II ; Journal Article ; Multicenter Study ; Research Support, N.I.H., Extramural
    ZDB-ID 2837553-1
    ISSN 2405-8521 ; 2405-8521
    ISSN (online) 2405-8521
    ISSN 2405-8521
    DOI 10.1016/j.pvr.2019.01.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top